Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Blueprint Medicines Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
BPMC
Nasdaq
8731
https://www.blueprintmedicines.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Blueprint Medicines Corp
Insiders Are Dumping These 10 Healthcare Stocks
- Mar 28th, 2024 12:13 pm
CRISPR Therapeutics (CRSP) Down 13.6% Since Last Earnings Report: Can It Rebound?
- Mar 22nd, 2024 3:30 pm
Why Is Halozyme Therapeutics (HALO) Up 5.3% Since Last Earnings Report?
- Mar 21st, 2024 3:30 pm
30 Biggest Biotechnology Companies in the World
- Mar 17th, 2024 12:50 pm
Blueprint Medicines Corp's Chief Commercial Officer Sells Company Shares
- Mar 15th, 2024 11:00 pm
Moderna (MRNA) Soars 8.7%: Is Further Upside Left in the Stock?
- Mar 12th, 2024 12:03 pm
Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mar 6th, 2024 9:01 pm
Q4 2023 Rigel Pharmaceuticals Inc Earnings Call
- Mar 6th, 2024 4:53 pm
Blueprint Medicines Highlights AYVAKIT® (avapritinib) Long-Term Efficacy and Safety Data and Advances in Mast Cell Disease Research at 2024 AAAAI Annual Meeting
- Feb 23rd, 2024 1:00 pm
Blueprint Medicines Full Year 2023 Earnings: Beats Expectations
- Feb 17th, 2024 12:36 pm
Here's What Key Metrics Tell Us About Blueprint Medicines (BPMC) Q4 Earnings
- Feb 16th, 2024 8:30 pm
Blueprint Medicines Corporation (NASDAQ:BPMC) Q4 2023 Earnings Call Transcript
- Feb 16th, 2024 2:37 pm
Blueprint (BPMC) Q4 Earnings Beat, Stock Up as Ayvakit Shines
- Feb 16th, 2024 10:47 am
Q4 2023 Blueprint Medicines Corp Earnings Call
- Feb 16th, 2024 3:50 am
Blueprint Medicines Surges After Rare-Disease Drug Notches Its Fourth Quarterly Beat
- Feb 15th, 2024 3:55 pm
Blueprint Medicines (BPMC) Reports Q4 Loss, Tops Revenue Estimates
- Feb 15th, 2024 1:25 pm
Blueprint Medicines Corp Reports Robust AYVAKIT Revenue Growth in Q4 and Full Year 2023
- Feb 15th, 2024 12:43 pm
Blueprint Medicines Reports Fourth Quarter and Full Year 2023 Results
- Feb 15th, 2024 12:00 pm
Drug, Biotech Stock Q4 Earnings Due on Feb 15: ALNY, BPMC & More
- Feb 14th, 2024 3:12 pm
Apellis Pharmaceuticals, Inc. (APLS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
- Feb 13th, 2024 3:00 pm
Scroll